GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Exam Corner/Dyssynergic Defecation

Dyssynergic Defecation

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated October 1, 2025

Quick Answer

**Dyssynergic Defecation (DD): Comprehensive Overview** ### **Definition and Prevalence** Dyssynergic defecation (DD) is a common subtype of chronic constipation, accounting for up to 50% of cases. It is characterized by impaired coordination between rectal propulsion and pelvic floor relaxation during defecation.


**Dyssynergic Defecation (DD): Comprehensive Overview**

### **Definition and Prevalence**

Dyssynergic defecation (DD) is a common subtype of chronic constipation, accounting for up to 50% of cases. It is characterized by impaired coordination between rectal propulsion and pelvic floor relaxation during defecation. Essentially, the muscles involved in the process of defecation fail to work in harmony, leading to difficulty in evacuating stool.

---

### **Pathophysiology**

Successful defecation requires synchronized activity of multiple processes:

1. **Rectal Pressure Generation**: The rectum must generate sufficient pressure to propel stool.

2. **Pelvic Floor Relaxation**: The pelvic floor muscles and anal sphincter must relax to allow stool passage.

3. **Anorectal Descent and Angle Widening**: The anorectal region must descend and widen to facilitate evacuation.

In DD, these processes are disrupted, often due to spastic pelvic floor dysfunction, which is the dominant abnormal phenotype in affected individuals.

---

### **Diagnostic Challenges**

Traditional diagnostic tools like high-resolution anorectal manometry (HR-ARM), balloon expulsion test (BET), and defecography are often performed separately and in different body positions. This reduces their ability to assess real-time coordination during defecation. As a result, diagnosing DD has been challenging.

---

### **Advances in Diagnosis: Proctomanometry**

A prospective study involving 120 participants (60 healthy, 60 constipated) introduced **synchronous proctomanometry**, a combined method that simultaneously measures:

  • **Anorectal pressures**
  • **Pelvic motion**
  • **Evacuation dynamics**

Proctomanometry demonstrated superior diagnostic accuracy compared to HR-ARM, especially in assessing real-time defecatory physiology. It provides a comprehensive understanding of the coordination required for successful defecation.

---

### **Key Findings from the Study**

1. **Evacuation Success Rates**:

  • 86% of healthy participants successfully evacuated ≥25% of rectal content.
  • Only 45% of constipated patients achieved this, confirming impaired evacuation in DD.

2. **Balloon Expulsion Test (BET)**:

  • BET times were significantly shorter in participants who could evacuate (31 ± 56 seconds) compared to those who could not (126 ± 76 seconds).
  • BET showed a strong negative correlation with rectal evacuation (r = –0.59; P < 0.001).

3. **Defecation Sequence**:

  • During the preparatory phase, rectal and anal pressures rose simultaneously.
  • Anorectal descent and angle widening followed, precursors to successful evacuation.
  • Evacuation began only when rectal pressure exceeded anal pressure, creating a **positive rectoanal gradient**, a critical marker of functional coordination.

4. **Evacuation Physiology**:

  • Higher rectal pressures, larger rectoanal gradients, greater anorectal descent, and wider angle changes were observed in evacuators compared to nonevacuators (P ≤ 0.001).

5. **Gender Differences**:

  • Men generated higher rectal pressures but showed less anorectal descent than women (P ≤ 0.04), suggesting sex-based mechanical differences in defecation.

---

### **Physiological Phenotypes**

The study identified four distinct defecatory phenotypes:

1. **Balanced Evacuation**: Normal pressure and motion; 100% evacuators.

2. **High-Pressure Evacuation**: Elevated rectal pressures with reduced anorectal descent; 84% evacuators.

3. **Low-Pressure Evacuation**: Low rectal pressures but moderate evacuation; 85% evacuators.

4. **Spastic Pelvic Floor**: Minimal anorectal motion and poor evacuation; 94% nonevacuators.

**Dominant Phenotype**:

  • 78% of DD patients fell into the "spastic pelvic floor" category, indicating a combination of propulsion and relaxation dysfunction.

---

### **Structural Findings**

Structural abnormalities were relatively uncommon but notable:

  • **Rectoceles (>1 cm)**: Found in 30% of women and correlated with higher evacuation pressures (P = 0.02).
  • **Enteroceles**: Present in 6%.
  • **Intussusception**: Observed in 10%.

These structural defects may contribute to evacuation difficulties in some patients.

---

### **Therapeutic Implications**

1. **Pelvic Floor Physical Therapy**:

  • Physical therapy targeting pelvic floor relaxation significantly improved symptoms (CRADI-8: –12.3; P = 0.009).
  • It also reduced anal electromyography activity (P < 0.001), validating its therapeutic potential.

2. **Biofeedback Therapy**:

  • Proctomanometry provides detailed insights into defecatory physiology, enabling personalized biofeedback therapy to retrain muscle coordination and improve evacuation.

---

### **Clinical Conclusion**

Successful defecation depends on synchronized rectal pressure generation, anorectal descent, and angle widening. Proctomanometry offers a more accurate diagnostic tool compared to traditional methods, allowing for targeted interventions such as biofeedback therapy or physical therapy. This approach holds promise for improving management and outcomes in patients with dyssynergic defecation.

Related Q&A

Dopamine Beyond Reward. JAMA| May 2026

This review redefines dopamine (DA) signaling beyond its classical role in reward processing, positioning dopaminergic circuits as central regulators of feeding behavior, metabolic sensing, and energy homeostasis. The authors describe how distributed dopamine ensembles across...

Gut–Heart Axis: Gut | May 2026

Introduction Atherosclerosis has traditionally been viewed as a lipid-driven disease. However, emerging evidence highlights a critical role of chronic inflammation and immune activation, with the gut microbiota now recognised as a key modulator of vascular...

Bleeding Risk with Apixaban vs. Rivaroxaban: NEJM March 2026

Clinical Summary In this randomized international trial (COBRRA), investigators compared the bleeding risk of apixaban vs. rivaroxaban in patients with acute venous thromboembolism (VTE), including pulmonary embolism and proximal deep-vein thrombosis. A total of 2,760...

ACG 2025

The American College of Gastroenterology (ACG) 2025 meeting is a prominent annual event where groundbreaking research, clinical studies, and advancements in gastroenterology are presented. At the ACG 2025 meeting, several impactful studies were showcased, providing...

Alcohol Use Disorder (AUD) with Alcohol-Related Liver Disease (ArLD) - Pharmacology

Alcohol Use Disorder (AUD) and Alcohol-Related Liver Disease (ArLD) often coexist, presenting a complex clinical challenge that requires careful consideration of pharmacological treatment. Below is a detailed explanation starting from definitions, the need for pharmacological...

The role of copper dysregulation in Wilson disease

Copper dysregulation plays a central role in the pathogenesis of Wilson disease (WD). The disease arises from the body’s inability to regulate copper levels, leading to its accumulation and subsequent toxicity. Below is a detailed...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer